Ki-67 Breast Cancer — SCE Medical Oncology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: C — High Ki-67 (>20-30%) indicates high tumour proliferation rate and is associated with higher recurrence risk and chemotherapy benefit
Ki-67 is a nuclear proliferation marker. High Ki-67 (>20-30%) correlates with higher recurrence risk and greater chemotherapy benefit in ER+/HER2- breast cancer. It is one of the factors in the St Gallen molecular subtype classification (Luminal A: low Ki-67; Luminal B: high Ki-67). While not included in Oncotype DX, Ki-67 ≥20% is one of the monarchE criteria for adjuvant abemaciclib eligibility.
Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/cancer